Pekin Hardy Strauss’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Pekin Hardy Strauss’s Portfolio LUMO Stock Details LUMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-389	Closed	-$127K	–	169
2015 Q4	$127K	Sell	389 -389	-50%	-$127K	0.03%	155
2015 Q3	$250K	Sell	778 -55	-7%	-$24.2K	0.06%	130
2015 Q2	$332K	Sell	833 -223	-21%	-$94.8K	0.06%	111
2015 Q1	$520K	Hold	1,056	–	–	0.1%	85
2014 Q4	$378K	Hold	1,056	–	–	0.06%	175
2014 Q3	$203K	Hold	1,056	–	–	0.03%	130
2014 Q2	$252K	Buy	+1,056	New	+$215K	0.04%	114

Other funds holding LUMO

First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Pekin Hardy Strauss's LUMO Position: Q1 2016 in Review

Pekin Hardy Strauss sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q1 2016, closing a stake of 222 shares — an estimated $73K sold.

Pekin Hardy Strauss first reported a position in LUMO in Q1 2015 and held it in 2 quarters. The position peaked at $73K in Q4 2015. 139 funds tracked by Wall St. Rank hold LUMO as of Q1 2016.

Pekin Hardy Strauss reported no remaining Lumos Pharma, Inc. Common Stock position as of Q1 2016 after selling out during the quarter.
Pekin Hardy Strauss sold 222 Lumos Pharma, Inc. Common Stock shares in Q1 2016, an estimated $73K.
Pekin Hardy Strauss first reported a position in Lumos Pharma, Inc. Common Stock in Q1 2015 and held it in 2 quarters.
Pekin Hardy Strauss's Lumos Pharma, Inc. Common Stock position peaked at $73K in Q4 2015.
139 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q1 2016.

Based on Pekin Hardy Strauss's 13F filing for Q1 2016, filed 9 May 2016.